Brief: Akero Therapeutics Q1 Operating Expenses USD 80.9 Million
12/05/2025 12:35
May 12 (Reuters) - Akero Therapeutics Inc AKRO.O: AKERO THERAPEUTICS Q1 OPERATING EXPENSES USD 80.9 MILLION AKERO THERAPEUTICS: QTRLY NET LOSS $0.90 PER SHARE Source text: ID:nGNX94dybN Further company coverage: AKRO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akero Therapeutics
See all newsBrief: Novo Nordisk Completes Acquisition Of Akero Therapeutics
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Germany's Cartel Office Says It Approved Acquisition Of Akero Therapeutics By Novo Nordisk
Brief: Akero Therapeutics Stockholders Approve Acquisition By Novo Nordisk